Immunotherapy with Keytruda (Pembolizumab) in Tel Aviv typically costs from $8,500 to $11,500 per treatment cycle. Pricing depends on the required dosage, the specific hospital tier, and necessary diagnostic mapping like genomic tumor profiling. Patients save around 47% compared to the US, where this procedure costs $21,500 on average. Quotes generally include the medication, nursing care, and oncologist monitoring during infusion.
Bookimed Expert Insight: Tel Aviv serves as the primary hub for oncology research in Israel, concentrating the country's highest volume of JCI-accredited facilities. This specialization allows clinics like Sourasky Medical Center to maintain a 90% success rate for oncology treatments. For international patients, choosing Tel Aviv provides direct access to experts like Professor Ofer Merimsky or Professor Ido Wolf. These specialists often lead national genomic medicine initiatives, ensuring that immunotherapy protocols are precisely matched to the patient's tumor profile.
| Israel | Turkey | Austria | |
| Immunotherapy with Keytruda (Pembolizumab) | from $9,800 | from $3,300 | from $15,000 |
Day 1
Day 2
Day 3
Day 4-5
Day 6
Day 7
Weeks 2-4
Please note that each patient"s experience may vary, and you should always follow the advice of your healthcare provider.
Principal investigator of clinical trials in cancer therapies – Dr. Sarid brings cutting-edge immunotherapy expertise to Sourasky Medical Center.
Dr. Pelles Sharon specializes in immunotherapy with Keytruda at Sourasky Medical Center, bringing extensive research and clinical expertise to cancer treatment.
Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – a pioneer in immunotherapy research for sarcoma.
Dr. Ram Ron specializes in Immunotherapy with Keytruda (Pembrolizumab) at Sourasky Medical Center (Ichilov), offering advanced treatment options.